Related Experiment Video
Updated: Jun 17, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
[Methylene blue therapy for vasoplegia after cardiac surgery]
Katarzyna Skuza1, Sergiusz Chmielniak, Wojciech Dziuk
1Oddział Kliniczny Kardioanestezji i Intensywnej Terapii, Slaski Uniwersytet Medyczny, Slaskie Centrum Chorób Serca w Zabrzu. kardanest@sum.edu.pl
Background:
Systemic inflammatory response syndrome (SIRS) may be associated with critically decreased vascular resistance (vasoplegia syndrome) and become resistant to noradrenaline. Such a condition may be successfully treated with intravenous methylene blue.
Case Report:
A 73-year-old patient with acute myocardial infarction and cardiogenic shock was admitted to our centre after failed percutaneous coronary interventions to the left anterior descending coronary artery and underwent emergency coronary revascularisation. After surgery, his ejection fraction was 25%. X-ray revealed pulmonary oedema. The patient became severely hypotensive with marked vasoplegia and metabolic acidosis, despite incremental doses of adrenaline and noradrenaline. 2 mg kg(-1) of methylene blue was administered, which quickly stabilized the patient's general condition.
Conclusion:
Methylene blue applied to vasoplegic patients can effectively increase systemic vascular resistance and restore satisfactory organ perfusion.
Related Concept Videos
Cardiac Catheterization IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Myocarditis III: Medical Management

